Filing Flows › VitaNova Life Sciences (VNOV) › Q1 FY27
VitaNova Life Sciences (VNOV) Q1 FY27 earnings results (first quarter fiscal 2027)
10-Q filed Sep 14, 2026
VitaNova Life Sciences (VNOV) reported revenue of $322K for the first quarter fiscal 2027 (Q1 FY27), +210% from a year earlier and -82% from the quarter before. Operating margin was -38.0%, net loss $123K (38.3% of revenue).
VitaNova Life Sciences, Q1 FY27: revenue $322K (+210% year over year), operating margin -38.0%, net loss $123K, operating cash flow $7K. The chart follows the revenue to costs, profit and cash.
| Q1 FY27 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $322K | -82% | +210% |
| Operating profit | −$122K | — | — |
| Net earnings | −$123K | -801% | — |
| Operating cash flow | $7K | -98% | -97% |
What changed
Revenue was $322K in Q1 FY27, up 210% year over year and down 82% from the previous quarter. Sale of Food Products was the largest line at 73% of revenue. Dietary Supplement Products declined 13%.
Gross margin was 9.5%, down 56.7 points from Q1 FY26. Operating costs exceeded revenue by $122K, an operating margin of -38.0%. Operating expenses grew 51% against revenue growth of 210%. The fastest-growing cost line was General & admin (+73%). The quarter ended with a net loss of $123K, after a profit of $18K the previous quarter.
Operating cash flow was $7K (down 97% year over year). Working capital and other items added $130K.
Questions
What was VitaNova Life Sciences' revenue in the first quarter fiscal 2027?
VitaNova Life Sciences (VNOV) reported revenue of $322K for the first quarter fiscal 2027 (Q1 FY27), +210% from a year earlier and -82% from the quarter before.
Was VitaNova Life Sciences profitable in the first quarter fiscal 2027?
Operating loss was $122K (-38.0% of revenue) and net loss $123K.